Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 08, 2026
DataAggregated Company Financials
Companies5
  • 7D0.8%
  • 3M-20.3%
  • 1Y17.5%
  • YTD-16.7%

The Biotech industry has been flat over the last week, but Zealand Pharma has lost 6.1%. The past year has been better, since the industry has gained 17% in that time. Earnings are forecast to grow by 2.7% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 08 Apr 2026DKK 142.5bDKK 39.5bDKK 14.0b10.9x10.2x3.6x
Fri, 06 Mar 2026DKK 150.2bDKK 40.1bDKK 15.0b5.9x10x3.7x
Sun, 01 Feb 2026DKK 169.6bDKK 40.3bDKK 18.9b6.1x9x4.2x
Tue, 30 Dec 2025DKK 177.6bDKK 40.5bDKK 19.0b6.1x9.4x4.4x
Thu, 27 Nov 2025DKK 179.4bDKK 40.9bDKK 19.1b6x9.4x4.4x
Sat, 25 Oct 2025DKK 169.9bDKK 39.0bDKK 16.8b13.3x10.1x4.4x
Mon, 22 Sep 2025DKK 162.9bDKK 38.8bDKK 16.7b12.7x9.7x4.2x
Wed, 20 Aug 2025DKK 140.3bDKK 38.8bDKK 16.7b10.6x8.4x3.6x
Fri, 18 Jul 2025DKK 127.7bDKK 27.1bDKK 7.4b11.3x17.3x4.7x
Sun, 15 Jun 2025DKK 138.2bDKK 27.2bDKK 7.4b11.6x18.7x5.1x
Tue, 13 May 2025DKK 125.9bDKK 28.0bDKK 7.9b10.1x15.9x4.5x
Thu, 10 Apr 2025DKK 114.7bDKK 27.3bDKK 7.7b10.3x14.9x4.2x
Sat, 08 Mar 2025DKK 156.9bDKK 27.3bDKK 7.7b13.3x20.4x5.7x
Mon, 03 Feb 2025DKK 158.5bDKK 26.0bDKK 4.7b16.5x33.8x6.1x
Wed, 01 Jan 2025DKK 160.9bDKK 26.0bDKK 4.7b16.7x34.3x6.2x
Fri, 29 Nov 2024DKK 163.4bDKK 26.0bDKK 4.7b17x34.8x6.3x
Sun, 27 Oct 2024DKK 179.0bDKK 25.5bDKK 5.5b21.3x32.7x7x
Tue, 24 Sep 2024DKK 191.9bDKK 25.5bDKK 5.5b23.3x35.1x7.5x
Thu, 22 Aug 2024DKK 199.2bDKK 26.1bDKK 5.7b20.3x34.7x7.6x
Sat, 20 Jul 2024DKK 195.0bDKK 24.8bDKK 5.6b18.2x34.6x7.9x
Mon, 17 Jun 2024DKK 172.3bDKK 24.8bDKK 5.6b17.2x30.6x6.9x
Wed, 15 May 2024DKK 184.1bDKK 25.2bDKK 6.2b16.4x29.9x7.3x
Fri, 12 Apr 2024DKK 183.8bDKK 23.9bDKK 5.0b19.4x36.5x7.7x
Sun, 10 Mar 2024DKK 193.7bDKK 23.9bDKK 5.0b19.9x38.5x8.1x
Tue, 06 Feb 2024DKK 167.8bDKK 23.3bDKK 4.2b22.8x40.3x7.2x
Thu, 04 Jan 2024DKK 174.6bDKK 23.3bDKK 4.2b25.7x41.9x7.5x
Sat, 02 Dec 2023DKK 173.8bDKK 23.3bDKK 4.2b25.2x41.8x7.5x
Mon, 30 Oct 2023DKK 158.4bDKK 22.0bDKK 4.7b18.5x33.4x7.2x
Wed, 27 Sep 2023DKK 198.1bDKK 22.0bDKK 4.7b23.2x41.8x9x
Fri, 25 Aug 2023DKK 197.9bDKK 22.0bDKK 4.7b23.7x41.9x9x
Sun, 23 Jul 2023DKK 211.1bDKK 19.5bDKK 4.4b41.8x47.9x10.8x
Tue, 20 Jun 2023DKK 204.3bDKK 19.5bDKK 4.4b42.5x46.4x10.5x
Thu, 18 May 2023DKK 216.2bDKK 17.9bDKK 4.0b33.3x54.1x12.1x
Sat, 15 Apr 2023DKK 212.7bDKK 17.9bDKK 3.5b33.3x60.1x11.9x
Price to Earnings Ratio

60.1x


Total Market Cap: DKK 212.7bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 29.3x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 10.2x which is lower than its 3-year average PE of 29.3x.
  • The 3-year average PS ratio of 6.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 30% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market1.05%
Healthcare1.06%
Biotech0.83%
Biotech0.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GMAB GenmabDKK 1.75k2.2%
+DKK 2.4b		38.1%PE17.3x
BAVA Bavarian NordicDKK 194.300.6%
+DKK 96.5m		31.4%PE10.9x
STRAP Strategic PartnersDKK 615.004.2%
+DKK 1.0m		-31.4%PS83x

Latest News

STRAP
DKK 615.00
Strategic Partners
7D
4.2%
1Y
-31.4%
BIOPOR
DKK 0.84
BioPorto
7D
-2.4%
1Y
-40.0%
BAVA
DKK 194.30
Bavarian Nordic
7D
0.6%
1Y
31.4%

BAVA: Expanded Vaccine Pipeline And New Contracts Will Support Higher Future Returns

Analysts have raised their price target on Bavarian Nordic from DKK 244.00 to DKK 280.00. They cite updated assumptions for revenue growth, profit margins, and a lower future P/E multiple that they view as better reflecting the company’s current outlook.
GMAB
DKK 1,751.50
Genmab
7D
2.2%
1Y
38.1%

GMAB: 2026 Late Stage Oncology Catalysts Will Support Stronger Margin Profile

Genmab's updated analyst price target now sits at DKK 3,017, a modest reset from DKK 3,060 as analysts factor in higher discount rates, revised long term margin expectations, and recent research that reflects both increased revenue growth assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research around Genmab has centered on how new clinical and portfolio developments filter into valuation, with several bullish analysts updating price targets and investment cases to reflect revised expectations on execution and long term growth potential.
ZEAL
DKK 276.90
Zealand Pharma
7D
-6.1%
1Y
-37.5%